MSLN and ovarian cancer: Lanitis et al. constructed MSLN scFv-CD3ζ and FRα scFv-CD28 CAR-T cells in trans that targeted MSLN and folate receptor-alpha (FRα), respectively, both of which are highly expressed in ovarian cancer cells [23, 87].